Stocks / Unknown

CGEM

Cullinan Therapeutics, Inc.
$21.741d +5.4%5d +3.5%settled close · 2026-09-17
β 1.7852w $5.75–23NASDAQ
Who’s talkingIdea Scout · free

Who’s talking about CGEM

No tracked investor commentary on CGEM yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 4 Nov 2026

Confirmed date · consensus EPS -0.87. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where CGEM’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 22 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-08-31
2026-08-28
2026-08-27
2026-08-26
2026-08-25
2026-08-19
2026-08-18
2026-08-14
2026-08-13
2026-08-12
2026-07-31
2026-07-24
2026-04-13
2026-04-08
2026-03-20
2026-03-12
2026-03-09
2026-03-06
2026-02-09
2026-01-28
2026-01-23
2026-01-22
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on CGEM is in this morning’s Brief. Get The Brief — $20/mo →